$IDPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOGEN INC.. Get notifications about new insider transactions in BIOGEN INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 34 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,965 | 0 | 8,751 | 6.8 K to 8.8 K (+28.96 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 319.43 | 588 | 187,825 | 6,786 | 7.4 K to 6.8 K (-7.97 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 319.43 | 358 | 114,356 | 7,374 | 7.7 K to 7.4 K (-4.63 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,104 | 0 | 7,732 | 6.6 K to 7.7 K (+16.66 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 10,960 | 0 | 10,960 | |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 1,357 | 0 | 6,314 | |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 1,799 | 0 | 7,671 | |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 1,263 | 0 | 2,527 | |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 319.43 | 539 | 172,173 | 6,520 | 7.1 K to 6.5 K (-7.64 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Buy | M | 0.00 | 1,799 | 0 | 7,059 | 5.3 K to 7.1 K (+34.20 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 319.43 | 380 | 121,383 | 5,260 | 5.6 K to 5.3 K (-6.74 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Buy | M | 0.00 | 1,263 | 0 | 5,640 | 4.4 K to 5.6 K (+28.86 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 860 | 0 | 860 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 6,260 | 0 | 6,260 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Option Exercise | A | 0.00 | 10,960 | 0 | 10,960 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 6,890 | 0 | 6,890 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 814 | 0 | 3,788 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 1,078 | 0 | 4,602 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 758 | 0 | 1,517 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 319.43 | 317 | 101,259 | 2,244 | 2.6 K to 2.2 K (-12.38 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 1,078 | 0 | 2,561 | 1.5 K to 2.6 K (+72.69 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 319.43 | 234 | 74,747 | 1,483 | 1.7 K to 1.5 K (-13.63 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 758 | 0 | 1,717 | 959 to 1.7 K (+79.04 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | A | 0.00 | 13,460 | 0 | 13,460 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | J | 0.00 | 1,697 | 0 | 7,894 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | M | 0.00 | 2,249 | 0 | 9,591 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | M | 0.00 | 1,578 | 0 | 3,157 | |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 319.43 | 798 | 254,905 | 6,841 | 7.6 K to 6.8 K (-10.45 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Buy | M | 0.00 | 2,249 | 0 | 7,639 | 5.4 K to 7.6 K (+41.73 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 319.43 | 469 | 149,813 | 5,390 | 5.9 K to 5.4 K (-8.00 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Buy | M | 0.00 | 1,578 | 0 | 5,859 | 4.3 K to 5.9 K (+36.86 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 12,520 | 0 | 12,520 | |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | A | 0.00 | 10,020 | 0 | 10,020 | |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,448 | 0 | 6,742 | |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,920 | 0 | 8,190 | |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,348 | 0 | 2,697 | |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 319.43 | 619 | 197,727 | 27,091 | 27.7 K to 27.1 K (-2.23 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,920 | 0 | 27,710 | 25.8 K to 27.7 K (+7.44 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 319.43 | 402 | 128,411 | 25,790 | 26.2 K to 25.8 K (-1.53 %) |
Feb 14 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,348 | 0 | 26,192 | 24.8 K to 26.2 K (+5.43 %) |
Feb 01 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 328.45 | 7,000 | 2,299,163 | 524,658 | 517.7 K to 524.7 K (+1.35 %) |
Feb 01 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 330.52 | 25,800 | 8,527,393 | 517,658 | 491.9 K to 517.7 K (+5.25 %) |
Feb 01 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 324.86 | 30,000 | 9,745,851 | 491,858 | 461.9 K to 491.9 K (+6.50 %) |
Jan 04 2019 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | J | 0.00 | 1,661 | 0 | 5,988 | |
Jan 04 2019 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,331 | 0 | 7,649 | |
Jan 04 2019 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Payment of Exercise | F | 304.69 | 414 | 126,142 | 917 | 1.3 K to 917 (-31.10 %) |
Jan 04 2019 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Buy | M | 0.00 | 1,331 | 0 | 1,331 | 0 to 1.3 K |
Dec 06 2018 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 265 | 0 | 265 | |
Dec 06 2018 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 530 | 0 | 530 | |
Dec 04 2018 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Option Exercise | J | 0.00 | 566 | 0 | 2,342 | |
Dec 04 2018 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Option Exercise | M | 0.00 | 602 | 0 | 2,908 | |
Dec 04 2018 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Payment of Exercise | F | 333.72 | 178 | 59,402 | 2,543 | 2.7 K to 2.5 K (-6.54 %) |
Dec 04 2018 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Buy | M | 0.00 | 602 | 0 | 2,721 | 2.1 K to 2.7 K (+28.41 %) |
Dec 04 2018 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Payment of Exercise | F | 333.72 | 231 | 77,089 | 2,119 | 2.4 K to 2.1 K (-9.83 %) |
Dec 03 2018 | IDPH | BIOGEN INC. | SCHENK LYNN | Director | Gift | G | 0.00 | 32 | 0 | 7,877 | 7.9 K to 7.9 K (-0.40 %) |
Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 175 | 0 | 5,164 | 5.3 K to 5.2 K (-3.28 %) |
Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 200 | 0 | 5,339 | 5.5 K to 5.3 K (-3.61 %) |
Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 200 | 0 | 5,539 | 5.7 K to 5.5 K (-3.48 %) |
Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 275 | 0 | 5,739 | 6 K to 5.7 K (-4.57 %) |
Sep 27 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Sell | S | 350.00 | 1,000 | 350,000 | 4,281 | 5.3 K to 4.3 K (-18.94 %) |
Aug 03 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 164 | 0 | 854 | |
Aug 03 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 262 | 0 | 1,018 | |
Aug 03 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 344.06 | 85 | 29,245 | 959 | 1 K to 959 (-8.14 %) |
Aug 03 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 344.06 | 78 | 26,837 | 1,044 | 1.1 K to 1 K (-6.95 %) |
Aug 03 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 262 | 0 | 1,122 | 860 to 1.1 K (+30.47 %) |
Jul 03 2018 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 1,760 | 0 | 1,760 | |
Jun 14 2018 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 880 | 0 | 10,909 | 10 K to 10.9 K (+8.77 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 880 | 0 | 7,210 | 6.3 K to 7.2 K (+13.90 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Grant | A | 0.00 | 880 | 0 | 18,587 | 17.7 K to 18.6 K (+4.97 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | Mulligan Richard | Director | Grant | A | 0.00 | 880 | 0 | 10,909 | 10 K to 10.9 K (+8.77 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | LEAMING NANCY | Director | Grant | A | 0.00 | 880 | 0 | 10,943 | 10.1 K to 10.9 K (+8.74 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Grant | A | 0.00 | 880 | 0 | 19,052 | 18.2 K to 19.1 K (+4.84 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,450 | 0 | 3,190 | 1.7 K to 3.2 K (+83.33 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 880 | 0 | 15,024 | 14.1 K to 15 K (+6.22 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | SCHENK LYNN | Director | Grant | A | 0.00 | 880 | 0 | 7,909 | 7 K to 7.9 K (+12.52 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 880 | 0 | 6,014 | 5.1 K to 6 K (+17.14 %) |
Jun 05 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | J | 0.00 | 1,110 | 0 | 2,502 | |
Jun 05 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | M | 0.00 | 1,384 | 0 | 3,612 | |
Jun 05 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 297.09 | 616 | 183,007 | 5,281 | 5.9 K to 5.3 K (-10.45 %) |
Jun 05 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Buy | M | 0.00 | 1,384 | 0 | 5,897 | 4.5 K to 5.9 K (+30.67 %) |
Jun 05 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 297.09 | 460 | 136,661 | 4,513 | 5 K to 4.5 K (-9.25 %) |
May 04 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 1,557 | 0 | 3,252 | |
May 04 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,687 | 0 | 4,809 | |
May 04 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 274.13 | 750 | 205,598 | 9,368 | 10.1 K to 9.4 K (-7.41 %) |
May 04 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 1,687 | 0 | 10,118 | 8.4 K to 10.1 K (+20.01 %) |
Apr 27 2018 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 269.91 | 48,000 | 12,955,680 | 461,858 | 413.9 K to 461.9 K (+11.60 %) |
Mar 05 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 312 | 0 | 848 | |
Mar 05 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 532 | 0 | 1,160 | |
Mar 05 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 282.35 | 237 | 66,917 | 4,302 | 4.5 K to 4.3 K (-5.22 %) |
Mar 05 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Buy | M | 0.00 | 532 | 0 | 4,539 | 4 K to 4.5 K (+13.28 %) |
Mar 05 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 282.35 | 405 | 114,352 | 4,007 | 4.4 K to 4 K (-9.18 %) |
Mar 05 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 531 | 0 | 531 | |
Feb 28 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Sell | S | 290.83 | 259 | 75,325 | 6,553 | 6.8 K to 6.6 K (-3.80 %) |
Feb 26 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 843 | 0 | 2,482 | |
Feb 26 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,635 | 0 | 3,325 | |
Feb 26 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 284.81 | 727 | 207,057 | 7,461 | 8.2 K to 7.5 K (-8.88 %) |
Feb 26 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,635 | 0 | 8,188 | 6.6 K to 8.2 K (+24.95 %) |
Feb 26 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 100 | 0 | 302 | |
Feb 26 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 194 | 0 | 402 | |
Feb 26 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 284.81 | 58 | 16,519 | 4,680 | 4.7 K to 4.7 K (-1.22 %) |
Feb 26 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 194 | 0 | 4,738 | 4.5 K to 4.7 K (+4.27 %) |
Feb 26 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Option Exercise | J | 0.00 | 843 | 0 | 2,482 | |
Feb 26 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Option Exercise | M | 0.00 | 1,635 | 0 | 3,325 | |
Feb 26 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Payment of Exercise | F | 284.81 | 727 | 207,057 | 24,368 | 25.1 K to 24.4 K (-2.90 %) |
Feb 26 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Buy | M | 0.00 | 1,635 | 0 | 25,095 | 23.5 K to 25.1 K (+6.97 %) |
Feb 21 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Sell | S | 292.00 | 743 | 216,956 | 6,553 | 7.3 K to 6.6 K (-10.18 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Sell | S | 298.85 | 1,294 | 386,712 | 7,296 | 8.6 K to 7.3 K (-15.06 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 3,144 | 0 | 17,002 | |
Feb 20 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,354 | 0 | 20,146 | |
Feb 20 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 299.38 | 1,877 | 561,936 | 8,356 | 10.2 K to 8.4 K (-18.34 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,354 | 0 | 10,233 | 4.9 K to 10.2 K (+109.74 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 787 | 0 | 4,254 | |
Feb 20 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,339 | 0 | 5,041 | |
Feb 20 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 299.38 | 596 | 178,430 | 8,590 | 9.2 K to 8.6 K (-6.49 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,339 | 0 | 9,186 | 7.8 K to 9.2 K (+17.06 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 95 | 0 | 514 | |
Feb 20 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 161 | 0 | 609 | |
Feb 20 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 299.38 | 56 | 16,765 | 4,544 | 4.6 K to 4.5 K (-1.22 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 161 | 0 | 4,600 | 4.4 K to 4.6 K (+3.63 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Option Exercise | J | 0.00 | 1,006 | 0 | 5,442 | |
Feb 20 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Option Exercise | M | 0.00 | 1,712 | 0 | 6,448 | |
Feb 20 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Payment of Exercise | F | 299.38 | 510 | 152,684 | 23,460 | 24 K to 23.5 K (-2.13 %) |
Feb 20 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Buy | M | 0.00 | 1,712 | 0 | 23,970 | 22.3 K to 24 K (+7.69 %) |
Feb 14 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | A | 0.00 | 11,840 | 0 | 11,840 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | A | 0.00 | 4,735 | 0 | 4,735 | |
Feb 14 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Option Exercise | A | 0.00 | 10,110 | 0 | 10,110 | |
Feb 14 2018 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Option Exercise | A | 0.00 | 4,045 | 0 | 4,045 | |
Feb 14 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 1,390 | 0 | 1,390 | |
Feb 14 2018 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 345 | 0 | 345 | |
Feb 14 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 9,470 | 0 | 9,470 | |
Feb 14 2018 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 3,790 | 0 | 3,790 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 5,680 | 0 | 5,680 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 2,275 | 0 | 2,275 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | A | 0.00 | 36,320 | 0 | 36,320 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 1,398 | 0 | 3,418 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 2,012 | 0 | 4,816 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 8,290 | 0 | 8,290 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 3,315 | 0 | 3,315 | |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 316.63 | 718 | 227,340 | 7,847 | 8.6 K to 7.8 K (-8.38 %) |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 2,012 | 0 | 8,565 | 6.6 K to 8.6 K (+30.70 %) |
Feb 14 2018 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 316.63 | 598 | 189,345 | 6,553 | 7.2 K to 6.6 K (-8.36 %) |
Jan 10 2018 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Option Exercise | M | 57.83 | 5,832 | 337,265 | 0 | |
Jan 10 2018 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 329.65 | 5,832 | 1,922,519 | 17,707 | 23.5 K to 17.7 K (-24.78 %) |
Jan 10 2018 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Buy | M | 57.83 | 5,832 | 337,265 | 23,539 | 17.7 K to 23.5 K (+32.94 %) |
Jan 04 2018 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 5,390 | 0 | 5,390 | |
Jan 04 2018 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 8,980 | 0 | 8,980 | |
Jan 02 2018 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | P | 320.55 | 780 | 250,029 | 4,879 | 4.1 K to 4.9 K (+19.03 %) |
Dec 05 2017 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Option Exercise | A | 0.00 | 1,755 | 0 | 1,755 | |
Dec 05 2017 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Mkt Acc & ... | Grant | A | 0.00 | 2,350 | 0 | 2,350 | 0 to 2.4 K |
Dec 05 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 319.35 | 103 | 32,893 | 4,439 | 4.5 K to 4.4 K (-2.27 %) |